Literature DB >> 3511898

Subconjunctival administration of ceftazidime in pigmented rabbit eyes.

R K Shockley, P Fishman, M Aziz, R A Yannis, W M Jay.   

Abstract

The ocular kinetics of ceftazidime, a third-generation cephalosporin, were examined in phakic and aphakic pigmented eyes of rabbits following subconjunctival injection (100 mg). Peak ceftazidime concentrations (mean +/- SE, n = three to five rabbits per determination) were as follows: phakic eyes, 40.2 +/- 7.3 mg/L in aqueous humor and 11.2 +/- 0.6 mg/L in vitreous humor at one hour; aphakic eyes, 30.5 +/- 4.8 mg/L in aqueous humor and 15.8 +/- 2.4 mg/L in vitreous humor at one hour. The ability of ceftazidime to eliminate an incipient bacterial infection was also studied. Ten aphakic rabbits received intravitreal injections of 50 colony-forming units (cfu) of Pseudomonas aeruginosa. Six of the ten immediately received a subconjunctival injection of ceftazidime (100 mg). At 48 hours following injections, four of four control eyes yielded bacterial counts greater than 6.2 X 10(6) cfu/mL. Of the six that received ceftazidime, five were sterile and one yielded 10 cfu/mL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511898     DOI: 10.1001/archopht.1986.01050140124033

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993

2.  Intravitreal penetration of oral pefloxacin in humans.

Authors:  M Oncel; G A Peyman
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

3.  Tolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits.

Authors:  S Marrakchi-Benjaafar; I Cochereau; F D'Hermies; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

4.  Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.

Authors:  Michael Engelbert; Herminia Miño de Kaspar; Martin Thiel; Thomas Grasbon; Christopher N Ta; Markus Schulze-Schwering; Volker Klauss; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-24       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.